Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Digestion|January 5, 2017
Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective StudyMasanao Nasuno, Maki Miyakawa, Hiroki Tanaka, et al.Medicine|August 11, 2023
Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn's disease in clinical remissionMasanao Nasuno, Hiroshi Shimazaki, Masanori Nojima, et al.Medicine|February 27, 2026
Improvement in small-bowel and colonic lesions observed by intestinal ultrasonography in Crohn's disease treated with risankizumabMaki Miyakawa, Masanao Nasuno, Masanori Nojima, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|October 12, 2016
A case of Takayasu's arteritis detected in a patient with Crohn's disease following infliximab treatmentMaki Miyakawa, Hiroki Tanaka, Masaki Yamashita, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 12, 2005
[A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively]Hiroyuki Okuda, Hiroki Tanaka, Masako Ueno, et al.Crohn'S & Colitis 360|July 2, 2026
Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohortTakahiro Ito, Atsuo Maemoto, Nobuhiro Ueno, et al.Inflammatory Intestinal Diseases|December 25, 2025
Long-Term Outcomes and Prognostic Factors for Vedolizumab-Treated Japanese Patients with Ulcerative ColitisShinya Fukushima, Takehiko Katsurada, Takahiro Ito, et al.Journal of Gastroenterology|November 13, 2013
Conditioned mesenchymal stem cells produce pleiotropic gut trophic factorsShuhei Watanabe, Yoshiaki Arimura, Kanna Nagaishi, et al.Journal of Gastroenterology|February 15, 2015
Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft modelSuguru Nakagaki, Yoshiaki Arimura, Kanna Nagaishi, et al.Inflammatory Intestinal Diseases|June 30, 2026
Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn's Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix CohortShinsuke Otagiri, Keiya Aoyama, Takehiko Katsurada, et al.Pageof 2